AVAC Comments to FDA in Support of PrEP Approval

AVAC Comments to FDA in Support of PrEP Approval

Download

Comments delivered to the FDA’s Antiviral Drugs Advisory Committee (AVDAC) Meeting by Mitchell Warren, Executive Director, AVAC.

Topics:: Accelerating Product Innovation; Advocating for Health Equity

Was this content helpful?

Yes, thanks Not really

Tell us how we can improve the content.

Was this content helpful?

Thanks you for your feedback!

Download PDF